Optical imaging is an emerging non-invasive technique used for capturing images of the internal parts of the body. Visible light and photons are incorporated to take the complete image of internal organs and tissues, the images of smaller structures are also taken, which include cells and molecules. Optical imaging uses the properties of photons such absorption and scattering, the spectra of light measures and perceives the properties of organs and soft tissues. Although, optical imaging technology is at its early phase of development, a wide range of technological advantages are offered over current imaging technologies. The images are referred by doctors for diagnosis and treatment of various diseases and by scientists for carrying out diverse research work. Optical imaging has proved to be much harmless and efficient compared to MRI and X-ray that use ionizing radiation for imaging.
The non-invasive technology and increasing prevalence is expected to boost the growth of optical imaging market
According to the World Health Organization in 2012, population above 65 years has grown the highest and is expected to rise from 13% in 2010 to 53% by 2020. The key factors contributing to the growth of the optical imaging market are high prevalence of neurological and ophthalmologic disorders, increase in R&D activities in the life sciences sector, preclinical research, rising demand for radiation free imaging modalities in drug discovery processes. Moreover, the provision to acquire in-depth images of complex components of eyes, surface tissues, membranes vascular systems and gastrointestinal tract are driving the growth of the global market. Furthermore, vast application scope of the advance optical imaging products, operator and patient safety and comfort are other factors driving the growth. The emerging state of optical imaging market is also due to the use of non-ionizing radiations that reduce the harmful radiation exposure of patients.
Development in healthcare infrastructure and rising prevalence of chronic diseases is expected to dominate North American optical imaging market
North America dominates the global optical imaging industry as the high usage of the optical imaging technologies in applications like oncology, dentistry and dermatology. It also comprises of huge geriatric population suffering from disorders that require optical imaging devices, which in turn will contribute towards the growth of optical imaging market. According to the National Institute of Aging in 2015, 524 million people were aged 65 or older in 2010 and by 2050 it is estimated to nearly triple to about 1.5 billion, which will represent 16 percent of the world’s population. Key factors responsible for the rapid growth of Asia-Pacific market is the presence of high patient population suffering from various disorders along with high prevalence of chronic diseases. Increasing healthcare awareness, development of healthcare infrastructure, growing purchase power will fuel the growth of global optical imaging market.
Key players operating in the optical imaging market are Abbott, Bioptigen, Inc., Topcon Medical systems, Inc., Carl Zeiss Meditec AG, Heidelberg Engineering, Inc., Santec Corporation, Headwall Photonics, Inc., AGFA Healthcare, Headwall Photonics, Inc. and Optovue, Inc.
Key Developments –
The global optical imaging market is segmented on the basis of product type, therapeutic area, application, end user and geography.
On the basis of product type,
On the basis of therapeutic area,
On the basis of applications,
On the basis of end user,
On the basis of Geography,